Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs WAVE Life Sciences Ltd. (WVE)

DBV Technologies S.A. and WAVE Life Sciences Ltd. are both Biotechnology companies. DBV Technologies S.A. and WAVE Life Sciences Ltd. are of similar size ($635.1M and $615.8M). DBV Technologies S.A. grew revenue faster over the last twelve months: −33.4% against −35.1%. WAVE Life Sciences Ltd. has the higher net margin (−296.9% vs −5,547.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, WAVE Life Sciences Ltd. leads on 11 and DBV Technologies S.A. on 5.

Valuation

Metric DBVT WVE Biotechnology median
P/E n/m n/m 10.60
P/S 255.21 9.68 9.40
P/B 6.42 1.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 210.91 3.60 9.02
Earnings yield (29.23%) (31.94%) (32.88%)
Free cash flow yield (20.11%) (30.37%) (23.13%)

Profitability

Metric DBVT WVE Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (5,571.63%) (320.94%) 0.00%
Net margin (5,547.30%) (296.86%) 0.00%
Free cash flow margin (5,131.50%) (293.83%) 0.00%
Return on equity (205.75%) (79.98%) (51.96%)
Return on assets (127.19%) (56.19%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DBVT WVE Biotechnology median
Revenue growth (TTM) (33.42%) (35.07%) 6.76%
EPS growth (last fiscal year) 10.26% (72.86%) 29.88%
Revenue growth, 5-year CAGR (12.95%) 16.31% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT WVE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.24 8.38 4.97
Net debt to EBITDA 1.35 2.92 1.01

Dividend

Metric DBVT WVE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DBVT WVE Biotechnology median
Market cap 615.83m 635.08m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack